ANAVEX LIFE SCIENCES CORP. Increase (Decrease) in Income Taxes Receivable
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Increase (Decrease) in Income Taxes Receivable of $186.00 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in income taxes receivable for the quarter ending 2026-06-30 was $63.00K, a 59.09% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in income taxes receivable for the quarter ending 2026-03-31 was $88.00K.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in income taxes receivable for the quarter ending 2025-12-31 was $35.00K, a 67.59% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in income taxes receivable for the quarter ending 2025-09-30 was -$11.00K, a 101.51% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in income taxes receivable for fiscal 2025 was -$1.64M.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in income taxes receivable for fiscal 2024 was -$260.00K.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in income taxes receivable for fiscal 2023 was -$484.00K.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in income taxes receivable for fiscal 2022 was -$5.94M, a 238.65% decline from fiscal 2021.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 3 month as first filed | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 6 month as first filed | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 9 month as first filed | Increase (Decrease) in Income Taxes Receivable 12 month | Increase (Decrease) in Income Taxes Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-28 | $151.00K derived: sum of 2 quarters · filed 2026-08-28 | $186.00K 10-Q · filed 2026-08-28 | $175.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2026-03-31 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-28 | $123.00K 10-Q · filed 2026-08-28 | $112.00K derived: sum of 3 quarters · filed 2026-08-28 | $266.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-12-31 | $35.00K 10-Q · filed 2026-02-09 | $24.00K derived: sum of 2 quarters · filed 2026-08-28 | $178.00K derived: sum of 3 quarters · filed 2026-08-28 | -$1.71M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-09-30 | -$11.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $143.00K derived: sum of 2 quarters · filed 2026-08-28 | -$1.75M derived: sum of 3 quarters · filed 2026-08-28 | -$1.64M 10-K/A · filed 2026-08-28 | ||||
| 2025-06-30 | $154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-28 | -$1.74M derived: sum of 2 quarters · filed 2026-08-28 | -$1.63M 10-Q · filed 2026-08-28 | -$900.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-03-31 | -$1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-28 | -$1.78M 10-Q · filed 2026-08-28 | -$1.05M derived: sum of 3 quarters · filed 2026-08-28 | -$3.12M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-12-31 | $108.00K 10-Q · filed 2026-02-09 | $837.00K derived: sum of 2 quarters · filed 2026-08-28 | -$1.23M derived: sum of 3 quarters · filed 2026-08-28 | -$992.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-09-30 | $729.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | -$1.34M derived: sum of 2 quarters · filed 2026-08-28 | -$1.10M derived: sum of 3 quarters · filed 2026-08-28 | -$260.00K 10-K/A · filed 2026-08-28 | ||||
| 2024-06-30 | -$2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | -$1.83M derived: sum of 2 quarters · filed 2025-08-12 | -$989.00K 10-Q · filed 2025-08-12 | -$446.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-03-31 | $236.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-13 | $1.08M 10-Q · filed 2025-05-13 | $1.62M derived: sum of 3 quarters · filed 2026-08-28 | -$953.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2023-12-31 | $840.00K 10-Q · filed 2025-02-12 | $1.38M derived: sum of 2 quarters · filed 2026-08-28 | -$1.19M derived: sum of 3 quarters · filed 2026-08-28 | -$546.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2023-09-30 | $543.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | -$2.03M derived: sum of 2 quarters · filed 2026-08-28 | -$1.39M derived: sum of 3 quarters · filed 2026-08-28 | -$484.00K 10-K/A · filed 2026-08-28 | ||||
| 2023-06-30 | -$2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-06 | -$1.93M derived: sum of 2 quarters · filed 2024-08-06 | -$1.03M 10-Q · filed 2024-08-06 | -$1.03M 10-Q · filed 2023-08-08 | -$4.39M derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | $643.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | $1.54M 10-Q · filed 2024-05-09 | $1.55M 10-Q · filed 2023-05-09 | -$1.82M derived: sum of 3 quarters · filed 2024-05-09 | -$1.73M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $902.00K 10-Q · filed 2024-02-07 | $901.85K 10-Q · filed 2023-02-07 | -$2.46M derived: sum of 2 quarters · filed 2024-02-07 | -$2.37M derived: sum of 3 quarters · filed 2024-02-07 | -$1.28M derived: sum of 4 quarters · filed 2024-02-07 | |||
| 2022-09-30 | -$3.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | -$3.28M derived: sum of 2 quarters · filed 2023-11-27 | -$2.18M derived: sum of 3 quarters · filed 2023-11-27 | -$5.94M 10-K · filed 2023-11-27 | -$5.94M 10-K · filed 2022-11-28 | |||
| 2022-06-30 | $90.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $1.19M derived: sum of 2 quarters · filed 2023-08-08 | -$2.58M 10-Q · filed 2023-08-08 | -$2.04M derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2022-03-31 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-09 | -$2.67M 10-Q · filed 2023-05-09 | -$2.13M derived: sum of 3 quarters · filed 2023-11-27 | -$859.59K derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2021-12-31 | -$3.76M 10-Q · filed 2023-02-07 | -$3.23M derived: sum of 2 quarters · filed 2023-11-27 | -$1.96M derived: sum of 3 quarters · filed 2023-11-27 | -$1.21M derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2021-09-30 | $535.08K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $1.81M derived: sum of 2 quarters · filed 2023-11-27 | $2.56M derived: sum of 3 quarters · filed 2023-11-27 | $4.29M 10-K · filed 2023-11-27 | $4.29M 10-K · filed 2021-11-24 | |||
| 2021-06-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-09 | $2.02M derived: sum of 2 quarters · filed 2022-08-09 | $3.75M 10-Q · filed 2022-08-09 | $5.05M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2021-03-31 | $750.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-10 | $2.48M 10-Q · filed 2022-05-10 | $3.78M derived: sum of 3 quarters · filed 2022-11-28 | $3.18M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-12-31 | $1.73M 10-Q · filed 2022-02-09 | $3.03M derived: sum of 2 quarters · filed 2022-11-28 | $2.43M derived: sum of 3 quarters · filed 2022-11-28 | $2.85M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-09-30 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $697.39K derived: sum of 2 quarters · filed 2022-11-28 | $1.12M derived: sum of 3 quarters · filed 2022-11-28 | $2.21M 10-K · filed 2022-11-28 | ||||
| 2020-06-30 | -$603.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | -$182.70K derived: sum of 2 quarters · filed 2021-08-12 | $905.23K 10-Q · filed 2021-08-12 | -$102.53K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $421.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-13 | $1.51M 10-Q · filed 2021-05-13 | $501.44K derived: sum of 3 quarters · filed 2021-05-13 | $1.07M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $1.09M 10-Q · filed 2021-02-16 | $80.17K derived: sum of 2 quarters · filed 2021-02-16 | $649.65K derived: sum of 3 quarters · filed 2021-02-16 | $1.46M derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | -$438.27K derived: sum of 2 quarters · filed 2020-12-28 | $368.50K derived: sum of 3 quarters · filed 2020-12-28 | $772.39K 10-K · filed 2020-12-28 | ||||
| 2019-06-30 | $569.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-06 | $1.38M derived: sum of 2 quarters · filed 2020-08-06 | $1.78M 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | $806.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | $1.21M 10-Q · filed 2020-05-07 | ||||||
| 2018-12-31 | $403.88K 10-Q · filed 2020-02-06 | |||||||
| 2018-09-30 | -$231.10K 10-K · filed 2019-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |